0001209191-14-071577.txt : 20141126
0001209191-14-071577.hdr.sgml : 20141126
20141126180520
ACCESSION NUMBER: 0001209191-14-071577
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141124
FILED AS OF DATE: 20141126
DATE AS OF CHANGE: 20141126
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYLAN INC.
CENTRAL INDEX KEY: 0000069499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251211621
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 MYLAN BOULEVARD
CITY: CANONSBURG
STATE: PA
ZIP: 15317
BUSINESS PHONE: 724-514-1800
MAIL ADDRESS:
STREET 1: 1000 MYLAN BOULEVARD
CITY: CANONSBURG
STATE: PA
ZIP: 15317
FORMER COMPANY:
FORMER CONFORMED NAME: MYLAN LABORATORIES INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: FRM CORP
DATE OF NAME CHANGE: 19711003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRESCH HEATHER M
CENTRAL INDEX KEY: 0001280753
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09114
FILM NUMBER: 141254642
MAIL ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
STREET 2: SUITE 400
CITY: CANONSBURG
STATE: PA
ZIP: 15317
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-11-24
0
0000069499
MYLAN INC.
MYL
0001280753
BRESCH HEATHER M
1000 MYLAN BLVD
CANONSBURG
PA
15317
1
1
0
0
Chief Executive Officer
Common Stock
2014-11-24
4
M
0
80222
22.14
A
373640
D
Common Stock
2014-11-24
4
S
0
80222
55.8575
D
293418
D
Common Stock
2014-11-25
4
M
0
19778
22.14
A
313196
D
Common Stock
2014-11-25
4
S
0
19778
55.5612
D
293418
D
Common Stock
1157
I
By 401(k) Plan
Employee Stock Option - Right to Buy
22.14
2014-11-24
4
M
0
80222
0.00
D
2017-01-31
Common Stock
80222
19778
D
Employee Stock Option - Right to Buy
22.14
2014-11-25
4
M
0
19778
0.00
D
2017-01-31
Common Stock
19778
0
D
Represents the weighted average price of the reporting person's disposition of 80,222 shares in transactions ranging from $55.27 to $56.11.
Represents the weighted average price of the reporting person's disposition of 19,778 shares in transactions ranging from $55.32 to $55.83.
The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 and 2 to this Form 4.
This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated November 9, 2014.
The options vested in four equal annual installments beginning on January 31, 2008.
/s/ Bradley L. Wideman, by power of attorney
2014-11-26